Renal Denervation Market segment, Global Trends, Share, Industry Size, Growth, Demand by 2030

Data Bridge Market Research analyzes that the global renal denervation market which was USD USD 789.43 million in 2022, would rocket up to USD 7,101.66 million by 2030, and is expected to undergo a CAGR of 31.60% during the forecast period.

"The world-class  Renal Denervation Market report has a lot to offer, serving as an absolute solution for exclusive market research data that suits business needs. It guides companies to take significant actions to address threats in the niche market. Market segmentation covered here is based on various parameters such as the type of product, its components, type of management, and geography. The Renal Denervation Market report provides numerous insights and business solutions that will aid in standing tall in the competition.

In the winning Renal Denervation Market report, market segmentation is systematically covered by considering several aspects that will undoubtedly help businesses. Moreover, this market research report makes professionals aware of the various strategies used by key players in the market. These strategies range from new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others that enhance their footprints in the Renal Denervation Market industry. An assessment and forecasting of market information using the best statistical and coherent models are performed here. Market share analysis and key trend analysis are major accomplishments in the credible Renal Denervation Market analysis report.

Data Bridge Market Research analyzes that the global renal denervation market which was USD USD 789.43 million in 2022, would rocket up to USD 7,101.66 million by 2030, and is expected to undergo a CAGR of 31.60% during the forecast period.

Explore Further Details about This Research Renal Denervation Market Report https://www.databridgemarketresearch.com/reports/global-renal-denervation-market

Renal Denervation Market Scope and Segmentation

REPORT METRIC

DETAILS

Forecast Period

2023 to 2030

Base Year

2022

Historic Year

2021 (Customizable to 2015 - 2020)

Quantitative Units

Revenue in USD Million, Volumes in Units, Pricing in USD

Segments Covered

By Product (Simplicity Renal Denervation System, Enlightn, Vessix Renal Denervation System, Paradise Renal Denervation System, Iberis Renal Sympathetic Denervation System), Technology (Radiofrequency, Ultrasound, Micro-Infusion, Pharmacologic), Type (Catheters, RF Generator, Nerve Modifying Agents), Indication (Hypertension, Heart Failure, Diabetes, Renal Failure), End User (Hospitals, Specialty Clinics, Research and Academic Institutes, Ambulatory Care Centers)

Countries Covered

U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, rest of Asia-Pacific, Saudi Arabia, U.A.E., South Africa, Egypt, Israel, rest of Middle East and Africa, Brazil, Argentina, and rest of South America

Market Players Covered

Medtronic (U.S.), Boston Scientific Corporation (U.S.), Abbott (U.S.), ReCor Medical, Inc. (U.S.), Johnson Johnson Private Limited (U.S.), Terumo Corporation (Japan), Mercator MedSystems,Inc. (U.S.), Ablative Solutions, Inc. (U.S.), SympleSurgical Inc. (U.S.), Kona Medical Inc. (U.S.),  Renal Dynamics Limited (U.K.), and Otsuka Medical Devices Co., Ltd. (Tokyo)

Market Opportunities

  • Funding For research and clinical activities
  • Development of new techniques

Market Definition

Renal denervation is a minimally-invasive catheter-based treatment that is used for hypertension. Radiofrequency ablation is used to burn nerves in the renal arteries. Nerve activity decreases and blood pressure decreases. If pharmacological treatment does not result in relief, this procedure is usually used to achieve better results. The nerves in the renal artery wall are removed using high-frequency pulses or ultrasound. It lowers blood pressure by reducing the activity of the sympathetic kidneys.

An increase in hypertension, heart failure, and chronic kidney disease indicates a significant and growing global health issue. Recently therapeutic strategies for these conditions are mainly based on lifestyle interventions and pharmacological approaches, but the rates of control of blood pressure and the therapeutic efforts to prevent the progression of heart failure need additional options. Renal denervation is a novel nonpharmacological intervention that involves a catheter-based ablation of the sympathetic nerve. Various technologies are used to detect in which the choice of each technique should be based upon the availability of resources according to patient requirements.

Global Renal Denervation Market Dynamics

Drivers

  • Increasing  prevalence of hypertension

Hypertension is becoming very common due to many factors such as depression, stress, co-morbid conditions, and several other factors. Renal denervation therapy has shown positive results to treat hypertension via using various forms of energy such as radiofrequency and ultrasound. It is proven to be effective in decreasing blood pressure both in the short and long term. Moreover, it reduces activity in renal nerves in kidneys to help lower blood pressure. For instance, according to the American Heart Association, more than 29 million people are estimated to have Blood Pressure (BP) exceeding professional society and guideline-recommended treatment goals in the U.S. alone in 2021.

  • Associated  beneficial factors

Renal denervation therapy has shown positive results in reducing hypertension. Therefore, the benefits offered by these therapies, such as long-lasting effects, shorter treatment times, and higher safety, are expected to drive market growth. In addition, advances in renal denervation devices have the potential to drive market growth. For instance, the development of catheter-based interventions to remove renal nerves has shown impressive results in managing blood pressure in patients with resistant hypertensive symptoms. In addition, catheter-based procedures appear to be safer for the patient and facilitate the denervation of selected nerves.

  • Increase in clinical trials 

An increase in clinical studies and RD associated with renal denervation devices and the long-term benefits of renal denervation procedures are expected to drive market growth. For instance, in April 2022, as per the article published in Nature, more than 80% of Thai patients with resistant hypertension experienced the success of the renal nerve denervation outcome, which was sustained over a longer follow-up without any intervention-related side effects.

Opportunities

  • Increase in healthcare expenditure and funding for research and clinical activities

The expansion of money used by a country on its healthcare and its growth rate over time is inclined by a wide variety of economic and social factors, including the financial agreements and structure of the organization of the health system. This will further create lucrative market growth opportunities. Furthermore, an upsurge in the public-private funding for target research activities, increasing chronic diseases, and rising product innovations and development demand owing to technological advancements all around the world are expected to provide profitable opportunities for market playerin the forecast period of 2023 to 2030.

  • Rising number of chronic diseases

Increasing the patient pool of other chronic diseases such as obesity among children and adults is expected to create opportunities for market growth in the forecast period.

As per the WHO’s statistics, over 39 million children aged below 5 years were overweight in 2021. This condition is likely to push the demand for renal nerve denervation therapy, as high leptin levels in obese people can trigger the growth of blood vessels in the hypothalamus, thereby causing hypertension.

  • Development of new techniques

The number of new skills introduced in the renal denervation approach is one of the main factors accelerating its adoption. A renal denervation system incorporating ultrasonic technology can overcome the limitations of high-frequency-based renal denervation systems. High-frequency sound waves with ultrasonic energy help remove nerves without close contact with tissue. This helps prevent damage to the renal arteries. Due to this characteristic, a significant number of patients around the world prefer this technique. In addition, integrating technology into these types of healthy habits will significantly improve the outcome of these techniques.

How  Renal Denervation Market Report Would Be Beneficial?

  • Anyone who are directly or indirectly connected in value chain of Renal Denervation Market industry and needs to have Know-How of market trends
  • Marketers and agencies doing their due diligence
  • Analysts and vendors looking for Renal Denervation Market intelligence about Renal Denervation Market Industry
  • Competition who would like to correlate and benchmark themselves with market position and standings in current scenario

Browse Related Reports:

Monilethrix Treatment Market to Receive Highest Growth of Billion by Size, Shares, Trends, Future Demand, Growth and Revenue Analysis

https://www.databridgemarketresearch.com/reports/global-monilethrix-treatment-market

Peritonitis Treatment Market to Grasp Outstanding Growth of Billion by Size, Share, Trends, Opportunities, Key Drivers and Growth Prospectus

https://www.databridgemarketresearch.com/reports/global-peritonitis-treatment-market

Pleural Effusion Drug Market to Observe Prominent CAGR Growth by Size, Share, Trends, Demand, Growth and Competitive Analysis

https://www.databridgemarketresearch.com/reports/global-pleural-effusion-drug-market

Restless leg syndrome Market to Perceive Highest Growth of Billion by Size, Share, Trends, Key Drivers, Growth, Challenges and Opportunity Forecast

https://www.databridgemarketresearch.com/reports/global-restless-leg-syndrome-market

shigellosis gastroenteritis treatment Market is Probable to Influence the Value of Billion by Size, Share, Trends, Growth, Demand, Challenges and Competitive Analysis

https://www.databridgemarketresearch.com/reports/global-shigellosis-gastroenteritis-treatment-market

Skin and Skin Structure Infections (SSSI) (Infectious Disease) treatment Market to Notice Prominent Growth of Billion by Size, Share, Trends, Demand, Industry Growth and Competitive Outlook

https://www.databridgemarketresearch.com/reports/global-skin-and-skin-structure-infections-treatment-market

Cutaneous Lupus Erythematosus Market Is Likely to Upsurge at Billion Globally by Size, Share, Trends, Demand, Growth and Opportunity Analysis

https://www.databridgemarketresearch.com/reports/global-cutaneous-lupus-erythematosus-market

Fibrate Drugs Market Size worth Billion Globally by Size, Share, Trends, Demand, Revenue Growth and Competitive Outlook

https://www.databridgemarketresearch.com/reports/global-fibrate-drugs-market

Fibromyalgia Market to Observe Prominent CAGR Growth by 2Size, Share, Trends, Demand, Market Growth and Competitive Analysis

https://www.databridgemarketresearch.com/reports/global-fibromyalgia-market

Hemophilia A Treatment Market To Perceive Highest CAGR Growth by Size, Share, Trends, Key Drivers, Growth Opportunities and Revenue Analysis

https://www.databridgemarketresearch.com/reports/global-hemophilia-a-treatment-market

About Data Bridge Market Research:

 US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Email – [email protected]

"

Mais artigos:

Procurar